Profile data is unavailable for this security.
About the company
Procaps Group SA is a Luxembourg-based healthcare and pharmaceutical company. The Company develops, manufactures and sells prescription drugs and products that are differentiated by their combinations and pharmaceutical forms, as well as nutritional supplements which include omega 3 fish oils and high-potency clinical compounds. It operates its business through 5 units which are Diabetrics, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties. Diabetrics provides diabetes solutions. Farma procaps formulates, manufactures and markets branded prescription drugs in Latin America. Softi Gel provides contract drug development and manufacturing services to third party pharmaceutical companies. Vital Care develops, manufactures and markets consumer healthcare products. Clinical Specialties develops, manufactures and markets complex drugs.
- Revenue in USD (TTM)414.10m
- Net income in USD52.20m
- Incorporated2021
- Employees5.50k
- LocationProcaps Group SA9, rue de BitbourgLUXEMBOURG 1273LuxembourgLUX
- Websitehttps://www.procapsgroup.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
LifeVantage Corp | 200.16m | 2.94m | 145.81m | 217.00 | 51.96 | 5.62 | 22.37 | 0.7285 | 0.2248 | 0.2248 | 15.51 | 2.08 | 3.17 | 2.66 | 87.77 | 922,414.80 | 4.65 | 9.95 | 6.95 | 15.55 | 79.30 | 81.45 | 1.47 | 3.08 | 1.01 | -- | 0.00 | 26.95 | -6.20 | -2.40 | 15.63 | -16.94 | -2.18 | -- |
Telomir Pharmaceuticals Inc | 0.00 | -18.74m | 161.67m | 1.00 | -- | 103.13 | -- | -- | -0.6855 | -0.6855 | 0.00 | 0.0529 | 0.00 | -- | -- | 0.00 | -467.16 | -- | -686.91 | -- | -- | -- | -- | -- | -- | -0.9299 | 0.00 | -- | -- | -- | -1,430.39 | -- | -- | -- |
Biostem Technologies Inc | 131.44m | 7.87m | 163.69m | 67.00 | 30.04 | 9.04 | 20.25 | 1.25 | 0.3346 | 0.3346 | 7.31 | 1.11 | 2.80 | 7.41 | 3.35 | -- | 16.78 | -- | 107.11 | -- | 94.73 | -- | 5.98 | -- | 1.20 | 15.52 | 0.2012 | -- | -- | -- | -- | -- | -- | -- |
Scilex Holding Co | 50.83m | -171.53m | 175.64m | 113.00 | -- | -- | -- | 3.46 | -1.40 | -1.40 | 0.4425 | -1.77 | 0.4401 | 5.22 | 1.55 | 484,123.80 | -102.93 | -- | -- | -- | 68.24 | -- | -233.88 | -- | 0.1853 | -3.72 | -- | -- | 22.90 | -- | -614.67 | -- | -- | -- |
Mediwound Ltd | 20.14m | -19.97m | 175.93m | 100.00 | -- | 8.48 | -- | 8.73 | -2.16 | -2.16 | 2.18 | 1.92 | 0.3311 | 5.53 | 6.55 | 201,410.00 | -32.83 | -24.48 | -49.28 | -32.92 | 13.25 | 43.27 | -99.17 | -38.43 | 1.51 | -3.26 | 0.2623 | -- | -29.48 | 40.60 | 65.73 | -- | 64.66 | -- |
Lifecore Biomedical Inc | 128.45m | 5.71m | 187.45m | 524.00 | 137.79 | -- | 13.02 | 1.46 | 0.0369 | 0.0595 | 3.82 | 1.28 | 0.5217 | 2.01 | 4.96 | 245,124.00 | 2.32 | -5.91 | 2.74 | -8.33 | 34.65 | 31.01 | 4.45 | -19.16 | 0.803 | 0.125 | 0.7641 | -- | 24.20 | -25.46 | 114.53 | 34.47 | -16.72 | -- |
Eton Pharmaceuticals Inc | 31.38m | -6.69m | 188.60m | 30.00 | -- | 13.96 | -- | 6.01 | -0.2596 | -0.2596 | 1.22 | 0.5229 | 1.00 | 8.82 | 7.89 | 1,046,033.00 | -21.31 | -46.22 | -38.27 | -58.20 | 59.48 | 72.16 | -21.31 | -76.86 | 1.28 | -- | 0.2571 | -- | 48.90 | -- | 89.62 | -- | 26.85 | -- |
ASP Isotopes Inc | 2.30m | -27.05m | 197.39m | 76.00 | -- | 14.01 | -- | 85.98 | -0.628 | -0.628 | 0.0549 | 0.2112 | 0.068 | -- | -- | 30,206.32 | -71.81 | -- | -89.44 | -- | 36.54 | -- | -1,055.85 | -- | -- | -8.11 | 0.6748 | -- | -- | -- | -229.34 | -- | -- | -- |
Scpharmaceuticals Inc | 24.05m | -60.64m | 203.62m | 135.00 | -- | 15.90 | -- | 8.47 | -1.56 | -1.56 | 0.6187 | 0.256 | 0.2678 | 0.6563 | 6.23 | 178,133.30 | -67.52 | -38.23 | -75.77 | -42.31 | 71.15 | -- | -252.18 | -1,360.16 | 3.66 | -13.66 | 0.8121 | -- | -- | -- | -48.79 | -- | -- | -- |
Amylyx Pharmaceuticals Inc | 298.76m | -165.87m | 209.69m | 384.00 | -- | 0.8024 | -- | 0.7019 | -2.45 | -2.45 | 4.34 | 3.84 | 0.7605 | 3.69 | 15.91 | 778,026.10 | -42.22 | -- | -50.91 | -- | 84.64 | -- | -55.52 | -- | 4.66 | -- | 0.00 | -- | 1,612.94 | -- | 124.84 | -- | -- | -- |
Inhibrx Biosciences Inc | 1.85m | 1.63bn | 221.05m | 166.00 | 0.126 | 1.01 | 0.135 | 119.29 | 121.21 | 121.21 | 0.0434 | 15.15 | 0.0079 | -- | 4.86 | 11,162.65 | 693.63 | -77.06 | 815.31 | -93.91 | -- | -- | 88,264.55 | -1,590.91 | -- | -21.96 | 0.00 | -- | -17.88 | -26.85 | -66.20 | -- | 26.30 | -- |
Precigen Inc | 4.39m | -135.38m | 242.71m | 202.00 | -- | 4.97 | -- | 55.30 | -0.5407 | -0.5407 | 0.0176 | 0.1709 | 0.0313 | -- | 4.71 | 21,727.72 | -96.46 | -31.50 | -119.34 | -38.63 | -13.56 | 44.00 | -3,084.55 | -232.32 | -- | -- | 0.00 | -- | -76.87 | -47.16 | -20.22 | -- | -48.30 | -- |
Procaps Group SA | 414.10m | 52.20m | 252.73m | 5.50k | 4.30 | 6.42 | 3.63 | 0.6103 | 0.5209 | 0.5209 | 4.16 | 0.3491 | 0.854 | 1.87 | 3.38 | 75,290.18 | 10.77 | -- | 19.01 | -- | 55.04 | -- | 12.61 | -- | 0.9861 | -- | 0.8829 | -- | 0.0434 | -- | 142.18 | -- | -- | -- |
Sanara Medtech Inc | 72.41m | -6.57m | 258.82m | 107.00 | -- | 6.21 | -- | 3.57 | -0.7788 | -0.7788 | 8.62 | 4.77 | 1.10 | 1.86 | 8.13 | 676,731.00 | -10.16 | -17.73 | -12.08 | -22.07 | 89.73 | 88.08 | -9.23 | -17.13 | 1.49 | -4.88 | 0.2577 | -- | 41.77 | 61.93 | 45.79 | -- | 99.09 | -- |
Rigel Pharmaceuticals Inc | 130.30m | -14.23m | 270.79m | 147.00 | -- | -- | -- | 2.08 | -0.8136 | -0.8136 | 7.45 | -1.70 | 1.06 | 1.05 | 5.24 | 886,401.40 | -11.59 | -28.82 | -19.93 | -47.26 | 92.41 | 97.88 | -10.92 | -35.76 | 1.48 | -1.73 | 2.00 | -- | -2.79 | 21.30 | 57.16 | -- | 68.45 | -- |
Holder | Shares | % Held |
---|---|---|
Credicorp Capital Asset Management SA AGFas of 31 Dec 2023 | 256.41k | 0.23% |
Lemanik Asset Management SAas of 30 Jun 2023 | 101.57k | 0.09% |
Geode Capital Management LLCas of 30 Jun 2024 | 28.94k | 0.03% |
Citadel Securities LLCas of 31 Mar 2024 | 12.50k | 0.01% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 12.36k | 0.01% |
Activest Wealth Management LLCas of 30 Jun 2024 | 10.00k | 0.01% |
RBC Dominion Securities, Inc.as of 31 Mar 2024 | 362.00 | 0.00% |
Pineridge Advisors LLCas of 30 Jun 2024 | 250.00 | 0.00% |
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024 | 100.00 | 0.00% |
UBS Securities LLCas of 31 Mar 2024 | 42.00 | 0.00% |